Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.

Authors:
Hung YW; Lee IC; Chi CT; Lee RC; Liu CA and 5 more

Journal:
Liver Cancer

Publication Year: 2023

DOI:
10.1159/000530950

PMCID:
PMC10857819

PMID:
38344446

Journal Information

Full Title: Liver Cancer

Abbreviation: Liver Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Statement Y.-H.H. has received research grants from Gilead Sciences and Bristol-Meyers Squibb and honoraria from Abbvie, Gilead Sciences, Bristol-Meyers Squibb, Ono Pharmaceutical, Merck Sharp and Dohme, Eisai, Eli Lilly, Ipsen, and Roche, and has served in an advisory role for Abbvie, Gilead Sciences, Bristol-Meyers Squibb, Ono Pharmaceuticals, Eisai, Eli Lilly, Ipsen, Merck Sharp and Dohme, and Roche. Other authors declare no conflicts of interest."

Evidence found in paper:

"The study was supported by grants from Taipei Veterans General Hospital, Taipei, Taiwan (V111A-001, V109C-048, V110C-144, V111C-107, V112C-070) and National Science and Technology Council, Taiwan (MOST 109-2314-B-010 -034 -MY3)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025